Filing Details
- Accession Number:
- 0001144204-13-033217
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-04 16:25:58
- Reporting Period:
- 2013-05-31
- Filing Date:
- 2013-06-04
- Accepted Time:
- 2013-06-04 16:25:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1230355 | Baxano Surgical Inc. | BAXS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1162059 | C Russell Hirsch | C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-31 | 2,009,806 | $2.28 | 2,009,806 | No | 4 | P | Indirect | Prospect Venture Partners III, L.P. |
| Common Stock | Acquisiton | 2013-05-31 | 3,330,810 | $0.00 | 5,340,616 | No | 4 | J | Indirect | Prospect Venture Partners III, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Prospect Venture Partners III, L.P. |
| No | 4 | J | Indirect | Prospect Venture Partners III, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2013-05-31 | 30,000 | $0.00 | 30,000 | $2.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2023-05-30 | No | 4 | A | Direct |
Footnotes
- The reportable securities are owned directly by Prospect Venture Partners III, L.P. Dr. Hirsch is a Managing Director of Prospect Venture Partners III, L.P., and has shared voting and dispositive power with respect to the shares held by Prospect Venture Partners III, L.P. Dr. Hirsch disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.
- Received in exchange for outstanding convertible promissory notes and shares of Series C Preferred Stock of Baxano, Inc. pursuant to the Agreement and Plan of Merger, dated March 3, 2013, by and among TranS1 Inc. (now Baxano Surgical, Inc.), RacerX Acquisition Corp., Baxano, Inc., and Sumeet Jain and David Schulte as Securityholder Representatives, as amended by the First Amendment to Agreement and Plan of Merger, dated April 10, 2013, by and among the parties.
- 25% of the stock option shall vest on May 31, 2014 and the remaining 75% of the stock option shall vest thereafter in 36 equal monthly installments.
Billionaire Hedge Funds
